Health Condition 1: C509- Malignant neoplasm of breast of unspecified site Health Condition 2: O- Medical and Surgical Health Condition 3: O- Medical and Surgical
Conditions
Interventions
Intervention1: intervention group: Flap fixation in Modified radical mastectomy using sutures
Intervention2: intervention group: Systemic administration of Octreotide during post operative period of
Sponsors
SRM Institute of science and Technology
Eligibility
Inclusion criteria
Inclusion criteria: Patients of all age groups with radiologically diagnosed & pathologically proven carcinoma breast planned for modified radical mastectomy Stage 2 and stage 3 carcinoma breast Patients who were fit for general anaesthesia Patients who consent to participate in the study
Exclusion criteria
Exclusion criteria: Patients who had undergone neoadjuvant chemotherapy Patients who had undergone previous ipsilateral breast surgery Patients who undergoes breast conservative surgery Stage 1 and Stage 4 carcinoma breast Patients having bleeding diathesis / uncontrolled diabetes mellitus / uncontrolled hypertension Patients who are severely obese BMI more than 40 Patients who had previous surgery in axillary lymphatic system Patients who do not consent to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Amount of fluid drainageTimepoint: 24hrs,36hrs and 48hrs | — |
Secondary
| Measure | Time frame |
|---|---|
| Wound infection Hospital stayTimepoint: 24hrs,36hrs,48hrs and 1 week | — |
Countries
India
Contacts
Public ContactAthira Gopinathan
SRM Institute of science and Technology
Outcome results
None listed